Using CRISPR to engineer a relative of the tomato, biologists have created a fruit that is easier to grow, potentially opening the door to breeding plants that are resistant to disease, pests or drought. In a recent study, scientists from Cold Spring Harbor Laboratory (NY, USA), Johns Hopkins...
Analysts said the deal makes sense for BioMarin, as it offers a late-stage clinical asset as well as two marketed therapies that generated nearly $450 million over the first nine months of this year.
Continue reading →
Novo Nordisk's application for CagriSema comes at the same time as competitor Eli Lilly's ask for its obesity drug orforglipron. Elsewhere, Merck & Co. and Pfizer succeeded in a bladder cancer study.
Continue reading →
A bankruptcy judge blocked an attempt by a nursing home chain’s primary investor to shield himself from settlement payments and liability in lawsuits alleging hundreds of patient injuries and deaths, encouraging those pursuing millions in damages. Genesis HealthCare, once the...
The FDA placed the hold after researchers recorded a “higher than anticipated” incidence of deaths in a study testing “I-DXd” in people with small cell lung cancer.
Continue reading →